Phase 4 Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older who have been diagnosed with type 2 diabetes and have been on the same diabetes treatment for at least three months.
- People whose blood sugar control measure (HbA1c) is between 7% and 10% while taking Metformin, with or without other diabetes tablets.
- People for whom a doctor has determined there is a clear medical reason to start a type of diabetes medication called an SGLT2 inhibitor.
- People with a body mass index (BMI) of 23 or higher (a measure of body weight relative to height).
- People who are willing to give written consent to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose blood sugar control measure (HbA1c) is above 10%, indicating poorly controlled diabetes.
- People who have used SGLT2 inhibitors, insulin, or a type of medication called GLP-1 receptor agonists in the 90 days before the trial starts.
- People who have had weight-loss (bariatric) surgery in the past, or who plan to have it during the study.
- People who drink large amounts of alcohol — roughly 14 or more standard drinks per week for women, or 21 or more standard drinks per week for men.
- People who are acutely unwell at the time of their outpatient clinic visit.
- People taking certain medications known to affect the liver, such as amiodarone, valproate, tamoxifen, methotrexate, or steroids.
- People whose kidneys are not functioning well enough, based on a specific kidney function measurement (eGFR below 45 mL/min/1.73 m²) (confirm with trial site).
- People who have a medical reason they cannot take SGLT2 inhibitors, including a history of repeated urinary or genital infections, current or previous gangrene, a known allergy to the medication, or a history of a serious diabetes complication called diabetic ketoacidosis.
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Change in HbA1c from baseline at 6 months; Change in weight from baseline at 6 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.